UNSPSC 85721360: Revision of autologous tissue substitute in right tarsal joint, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in right tarsal joint, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0SWH07Z

UNSPSC 85721360 Revision of autologous tissue substitute in right tarsal joint, open approach is a Commodity code with no recent state and local procurement activity aligned to its nominal medical procedure scope. The recent opportunities tagged under this code—independent medical evaluation services for pension disability determinations, surgical benefit carve-out programs, occupational medical surveillance, specialty healthcare for detained youth, pharmacy benefit management, and temporary health professional staffing—are administrative, contracting, and staffing services for health systems and benefits programs, not orthopedic surgical procedures or tissue engineering interventions. The mismatch between the code's clinical procedure name and the actual buying activity reflected in current solicitations suggests either a classification error in how opportunities were tagged or that this code is not the appropriate taxonomy match for the work state and local buyers are actually procuring.

State and local health systems and public employee benefits programs are actively sourcing medical administration and workforce services through these vehicles—the City of Phoenix Retirement Office and Phoenix Police Pension Board sought independent medical evaluation services (RFP RTMRFP26001, proposals due October 16, 2026); the City of Long Beach requested surgical benefit carve-out programs for its Anthem PPO plan (RFP HR26753, due October 7, 2026); and the Washington State Department of Transportation's Ferries Division procured occupational medical surveillance across 14 statewide locations (RFP RFP20260825, due October 9, 2026). Geographic activity spans Arizona, California, Washington, Florida, and Texas. However, none of these solicitations address tissue substitutes, joint revision procedures, or the surgical implant and biomaterial procurement that the code nominally describes. Vendors evaluating this code should verify accurate UNSPSC tagging through the issuing procurement office before committing bid preparation resources.